Clinical Implementation of 177Lu-PSMA-617 in the United States: Lessons Learned and Ongoing Challenges

被引：8
作者：
Ravi, Praful [1 ]
Whelpley, Bridget [1 ]
Kelly, Emma [1 ]
Wolanski, Andrew [1 ,2 ]
Ritzer, Jolivette [1 ,2 ]
Robertson, Matthew [1 ,2 ]
Shah, Hina [1 ,2 ]
Morgans, Alicia K. [1 ]
Wei, Xiao X. [1 ]
Sunkara, Rajitha [1 ]
Pomerantz, Mark [1 ]
Taplin, Mary -Ellen [1 ]
Kilbridge, Kerry L. [1 ]
Choudhury, Atish D. [1 ]
Jacene, Heather [1 ,2 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Boston, MA USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2023年 / 64卷 / 03期
关键词：
RESISTANT PROSTATE-CANCER; MULTICENTER; THERAPY;
D O I：
10.2967/jnumed.122.265194
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：349 / 350
页数：2
相关论文
共 45 条
  • [31] Correlation of an Index-Lesion-Based SPECT Dosimetry Method with Mean Tumor Dose and Clinical Outcome after 177Lu-PSMA-617 Radioligand Therapy
    Voelter, Friederike
    Mittlmeier, Lena
    Gosewisch, Astrid
    Brosch-Lenz, Julia
    Gildehaus, Franz Josef
    Zacherl, Mathias Johannes
    Beyer, Leonie
    Stief, Christian G.
    Holzgreve, Adrien
    Ruebenthaler, Johannes
    Cyran, Clemens C.
    Boning, Guido
    Bartenstein, Peter
    Todica, Andrei
    Ilhan, Harun
    DIAGNOSTICS, 2021, 11 (03)
  • [32] Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
    Herrmann, Ken
    Rahbar, Kambiz
    Eiber, Matthias
    Sparks, Richard
    Baca, Nicholas
    Krause, Bernd J.
    Lassmann, Michael
    Jentzen, Walter
    Tang, Jun
    Chicco, Daniela
    Klein, Patrick
    Blumenstein, Lars
    Basque, Jean-Rene
    Kurth, Jens
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (01) : 71 - 78
  • [33] Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer 177Lu-PSMA-617 therapy
    Bilgin, Gokce Belge
    Bilgin, Cem
    Childs, Daniel S.
    Orme, Jacob J.
    Burkett, Brian J.
    Packard, Ann T.
    Johnson, Derek R.
    Thorpe, Matthew P.
    Riaz, Irbaz Bin
    Halfdanarson, Thorvardur R.
    Johnson, Geoffrey B.
    Sartor, Oliver
    Kendi, Ayse Tuba
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [34] Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to 177Lu-PSMA-617: A Retrospective Multicenter Cohort Study
    Raychaudhuri, Ruben
    Mo, George
    Tuchayi, Abuzar Moradi
    Graham, Laura
    Gulati, Roman
    Pritchard, Colin C.
    Haffner, Michael C.
    Yezefski, Todd
    Hawley, Jessica E.
    Cheng, Heather H.
    Yu, Evan Y.
    Grivas, Petros
    Montgomery, Robert B.
    Nelson, Peter S.
    Chen, Delphine L.
    Hope, Thomas
    Iravani, Amir
    Schweizer, Michael T.
    JCO PRECISION ONCOLOGY, 2024, 8
  • [35] Population pharmacokinetic dosimetry model using imaging data to assess variability in pharmacokinetics of 177Lu-PSMA-617 in prostate cancer patients
    Siebinga, Hinke
    Prive, Bastiaan M.
    Peters, Steffie M. B.
    Nagarajah, James
    Dorlo, Thomas P. C.
    Huitema, Alwin D. R.
    de Wit-van der Veen, Berlinda J.
    Hendrikx, Jeroen J. M. A.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2023, 12 (08): : 1060 - 1071
  • [36] Clinical translation of 177Lu-labeled PSMA-617: Initial experience in prostate cancer patients
    Das, Tapas
    Guleria, Mohini
    Parab, Anil
    Kale, Chanchala
    Shah, Hina
    Sarma, Haladhar D.
    Lele, Vikram R.
    Banerjee, Sharmila
    NUCLEAR MEDICINE AND BIOLOGY, 2016, 43 (05) : 296 - 302
  • [37] Salvage Radioligand Therapy with Repeated Cycles of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer with Diffuse Bone Marrow Involvement
    Groener, Daniel
    Baumgarten, Justus
    Haefele, Sebastian
    Happel, Christian
    Klimek, Konrad
    Mader, Nicolai
    Ngoc, Christina Nguyen
    Tselis, Nikolaos
    Chun, Felix K. H.
    Gruenwald, Frank
    Sabet, Amir
    CANCERS, 2021, 13 (16)
  • [38] Dual-Time-Point Posttherapy 177Lu-PSMA-617 SPECT/CT Describes the Uptake Kinetics of mCRPC Lesions and Prognosticates Patients' Outcome
    Straub, Manuela
    Kupferschlaeger, Jurgen
    Higuita, Lina Maria Serna
    Weissinger, Matthias
    Dittmann, Helmut
    la Fougere, Christian
    Fiz, Francesco
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (09) : 1431 - 1438
  • [39] Dosimetry of 177Lu-PSMA-617 after Mannitol Infusion and Glutamate Tablet Administration: Preliminary Results of EUDRACT/RSO 2016-002732-32 IRST Protocol
    Sarnelli, Anna
    Belli, Maria Luisa
    Di Iorio, Valentina
    Mezzenga, Emilio
    Celli, Monica
    Severi, Stefano
    Tardelli, Elisa
    Nicolini, Silvia
    Oboldi, Devil
    Uccelli, Licia
    Cittanti, Corrado
    Monti, Manuela
    Ferrari, Mahila
    Paganelli, Giovanni
    MOLECULES, 2019, 24 (03)
  • [40] Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohort
    Calais, Jeremie
    Gafita, Andrei
    Eiber, Matthias
    Armstrong, Wesley R.
    Gartmann, Jeannine
    Thin, Pan
    Nguyen, Kathleen
    Lok, Vincent
    Gosa, Laura
    Grogan, Tristan
    Esfandiari, Rouzbeh
    Allen-Auerbach, Martin
    Quon, Andrew
    Bahri, Shadfar
    Gupta, Pawan
    Gardner, Linda
    Ranganathan, David
    Slavik, Roger
    Dahlbom, Magnus
    Herrmann, Ken
    Delpassand, Ebrahim
    Fendler, Wolfgang P.
    Czernin, Johannes
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (10) : 1440 - 1446
12345